What is Esperion Therapeutics's change in other assets?

Esperion Therapeutics (ESPR) reported change in other assets of $17.34M in Q1 2026.

How has Esperion Therapeutics's change in other assets changed year-over-year?

Esperion Therapeutics's change in other assets increased by 252.0% year-over-year, from $4.93M to $17.34M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Esperion Therapeutics ESPR Change in Other Assets

Change in Other Assets at other companies

AmgenAMGN

-$8M-104%

Lexicon PharmaceuticalsLXRX

$319K+126%

Zevra Therapeutics, Inc.ZVRA

-$2.05M-618%

Eton Pharmaceuticals, Inc.ETON

-$1.75M+41.0%

Nurix Therapeutics, Inc.NRIX

-$1.29M-121%

BridgeBio PharmaBBIO

$18.85M+3,770%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's change in other assets?: Esperion Therapeutics (ESPR) reported change in other assets of $17.34M in Q1 2026.
How has Esperion Therapeutics's change in other assets changed year-over-year?: Esperion Therapeutics's change in other assets increased by 252.0% year-over-year, from $4.93M to $17.34M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.